Patient Profile Preferred By Doctors For Polypill Prescription Essay

Many studies were conducted on coronary artery disease (CAD) because it is the leading cause of mortality and premature disability so studies investigated those at risk of coronary atherosclerosis aiming to provide early treatment (Kolovou et al., 2005), (Akhabue et al., 2014).

Currently, Heart disease is the leading cause of death among women in the United States (Haskell et al., 2014). In the 2016 Update of the Heart Disease and Stroke Statistics report from the American Heart Association, women, in general, have a 32% prevalence rate for LDL issues vs. 31% for men. Likewise, in older women vs older men, the prevalence for hypertension rates for women were 57% vs. 54% in men (Mozaffarian et al., 2016). Within the VA, there is an even bigger gap for management of LDL’s and heart disease. 79.47% of women vs. 88.89% of men have LDL levels within the normal limits. Similarly, 79.34% of women vs. 85.67% of men with diabetes had an LDL within normal limits (Whitehead et al., 2014). Both high LDL and hypertension are proven risk factors for heart disease and stroke. When paired with diabetes, risk of peripheral artery disease, heart failure, and irregular heartbeat can also be factors (Mozaffarian et al., 2016).

The 2016 USPSTF guidelines for the prevention of CVD are highly credible and demonstrate a thorough evaluation of credible evidence and provided understandable and easily applied practice recommendations. The guidelines can be readily applied to a variety of health care settings and providers to promote the long-term health of their patients. Recent updates in 2016 ensure that the most evidence-based information has been applied in their formulation. Use of these guidelines will help reduce the risk of CVD while minimizing complications attributed to the

The twenty-first century has seen pharmaceutical companies grow in unprecedented size and strength. Due to the unprecedented growth the larger pharmaceutical companies have gained leverage and power in the prescription drug industry, but they lack innovation to market and they seek ways to help the business continue to increase its profits. The pharmaceutical industry was once ethically sound and was a valuable player in the development of human health. However, overtime with the lack of innovation pharmaceutical companies are becoming an unethical market that exploits patients, doctors and anyone else it can to increase its profitability. With eyes only on profitability this can create a hazard for patients because there

How much knowledge do we have about the medications that we are prescribed from our physician? We don’t always as patients get to much knowledge about the medications from our doctor and we rarely ask the pharmacist about any concerns, and how many of us really have taken the time to read the description of the medications that is stapled onto the medication bag. I must confess I am not very good about that myself.

Cardiovascular disease is a substantial concern and has emerged as one of the leading health issues. In examining cardiovascular disease, its incidence is astounding. Each year approximately one million men and women die, averaging one death every thirty three seconds (Heart, 2013).The death rate for cardiovascular issues such as myocardial infarction and CHF claim more lives than cancer and Aids combined. Heart disease will be the number one cause of death by the

In addition to scholastic achievement, well rounded physicians have plenty of life experiences. They have fought through tragedies, yet find reasons to smile. They demonstrate success and leadership in spite of past failures. Their story may not be glamorous, but they consistently overcome obstacles that would stifle others. Their drive and determination defines who they are. The physician that emphasizes the well being of others over personal gain, that is the physician I plan to be. My path towards becoming a physician has been difficult in order to shape me into a more complete person. These past experiences allow me to sympathize, empathize, and more supportive of patients in the primary care setting. I feel the need to use my personal

Congestive Heart Failure (CHF) is a foremost health problem worldwide, touching 4.8 million U.S. patients and accounts for 978,000 or 5-10% of all hospitalizations. Some estimates show 550,000 new cases of CHF diagnosed each year in the United States alone. Currently, CHF accounts for 20% of all discharges in the over age 65 categories; with the aging demographic, this statistic is expected to increase significantly. Overall, the cost of treating CHF is very high -$38 billion annually in the U.S., representing 5.4% of total health care costs and involves many physician visits - at least 11 million ambulatory visits per year. The mortality rate for CHF is high, with one in five persons dying within 1 year, more than half of the CHF patients

Over the past years, heart disease has constituted one of the leading causes death in America. In fact, statistics show that one in every seven deaths is as a result of heart-related diseases (American Heart Association, 2016). Conversely, most deaths reported are of elderly individuals aged above the 65 years. However, there are also other underlying conditions that elevate the risk of developing heart diseases. According to the American Heart Association (2016) 62% of men and 67.8% of women have high blood pressure that are aged between 65-74 years of age. High blood pressure exposes older people to high-risk chances of developing cardiovascular diseases, characterized by high rates of mortality, morbidity, and disability. Cardiovascular

Heart failure is a debilitating syndrome that has driven up health care costs (O’Donovan, 2014). Therefore, making heart failure one of the most expensive chronic diseases. Heart failure is one of the most prevalent chronic diseases in the U.S. It is the only cardiovascular disorder that is increasing in both incidence and prevalence (Park, Wortmann, & Edmondson, 2011). The current treatment for heart failure is known to improve survival, but the quality of life may be compromised. Routine implementation of clinical guidelines may lead to a standardization of care, which could affect the patient-centered care that is needed in today’s healthcare (Sanders, Harrison, & Checkland, 2010). It is imperative that each patient’s care plan be

I recently graduated from Harding University with a degree in Exercise Science. While obtaining this degree, I learned how great my compassion for the human body really is. One of my favorite classes as an undergraduate was Exercise Prescription for different Populations. My professor really pushed us to explore new topics and expand our knowledge. Learning how people with different diseases or problems with their body adapt to different exercise techniques to keep them

While looking forward, as the population is aging there is added pressure in the pharma-care program. When Canada makes reforms in their system of control for drug expenditures might become a next step as well. Currently in Canada all provinces and territories have different public drug benefits plans made available to them. Alberta has different prescription drug programs such as non-group coverage (which requires a premium to be paid), coverage for seniors who are 65 or over in age, palliative coverage and diabetic supply coverage (Alberta Health, 2017). Manitoba’s pharma-care program is based on the total family income and the amount you pay for eligible prescription drugs and later you are paid the annual premium which is the

Cardiovascular diseases (CVDs) are the most common cause of mortality worldwide, especially in developed countries. But they are also largely preventable, and many studies have tried to clarify the related risk factors, and what could be done to avoid them.

The Heart Association of Australia considered PAD as a coronary artery disease (CAD) risk equivalent, thus screening and treatment is considered important. There are currently no Australian guidelines recommending routine screening for PVD, although screening should be considered in people over 50 years of

As the population ages heart failure is expected to increase exceptionally. About twenty-two percent of men and forty-four percent of women will develop heart failure within six years of having a heart attack. “Thirty years ago patients would have died from their heart attacks!” (Couzens)